These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 23832978)

  • 1. [Current and future aspects of intravenous thrombolysis for acute stroke].
    Toyoda K
    Brain Nerve; 2013 Jul; 65(7):753-60. PubMed ID: 23832978
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Remote ischemic perconditioning in thrombolysed stroke patients: randomized study of activating endogenous neuroprotection - design and MRI measurements.
    Hougaard KD; Hjort N; Zeidler D; Sørensen L; Nørgaard A; Thomsen RB; Jonsdottir K; Mouridsen K; Hansen TM; Cho TH; Nielsen TT; Bøtker HE; Østergaard L; Andersen G
    Int J Stroke; 2013 Feb; 8(2):141-6. PubMed ID: 22463392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Perfusion computed tomography-guided intravenous thrombolysis for acute ischemic stroke beyond 4.5 hours: a case-control study.
    García-Bermejo P; Calleja AI; Pérez-Fernández S; Cortijo E; del Monte JM; García-Porrero M; Fe Muñoz M; Fernández-Herranz R; Arenillas JF
    Cerebrovasc Dis; 2012; 34(1):31-7. PubMed ID: 22759450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Prospects of thrombolytic therapy for acute ischemic stroke].
    Nakashima T; Minematsu K
    Brain Nerve; 2009 Sep; 61(9):1003-12. PubMed ID: 19803399
    [TBL] [Abstract][Full Text] [Related]  

  • 5. SYNTHESIS expansion: design of a nonprofit, pragmatic, randomized, controlled trial on the best fast-track endovascular treatment vs. standard intravenous alteplase for acute ischemic stroke.
    Ciccone A; Valvassori L; Nichelatti M;
    Int J Stroke; 2011 Jun; 6(3):259-65. PubMed ID: 21557814
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Intravenous administration of a tissue plasminogen activator beyond 3 hours of the onset of acute ischemic stroke--MRI-based decision making].
    Kakuda W; Abo M
    Brain Nerve; 2008 Oct; 60(10):1173-80. PubMed ID: 18975605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of arterial and venous brain ischemia. Experts' recommendations: stroke management in the intensive care unit].
    Calvet D; Bracard S; Mas JL;
    Rev Neurol (Paris); 2012 Jun; 168(6-7):512-21. PubMed ID: 22647807
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TESPI (Thrombolysis in Elderly Stroke Patients in Italy): a randomized controlled trial of alteplase (rt-PA) versus standard treatment in acute ischaemic stroke in patients aged more than 80 years where thrombolysis is initiated within three hours after stroke onset.
    Lorenzano S; Toni D;
    Int J Stroke; 2012 Apr; 7(3):250-7. PubMed ID: 22292526
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Time is Penumbra: imaging, selection and outcome. The Johann jacob wepfer award 2014.
    Davis S; Donnan GA
    Cerebrovasc Dis; 2014; 38(1):59-72. PubMed ID: 25227260
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of tissue plasminogen activator in acute ischemic stroke.
    Hatcher MA; Starr JA
    Ann Pharmacother; 2011 Mar; 45(3):364-71. PubMed ID: 21386027
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The future perspective of acute thrombolytic therapy for acute ischemic stroke].
    Matsuki T; Toyoda K
    Nihon Rinsho; 2016 Apr; 74(4):613-20. PubMed ID: 27333749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Thrombolysis by intravenous tissue plasminogen activator (t-PA)--current status and future direction].
    Tanahashi N
    Brain Nerve; 2009 Jan; 61(1):41-52. PubMed ID: 19177806
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intravenous thrombolysis in acute ischemic stroke: standard and potential future applications.
    Haršány M; Tsivgoulis G; Alexandrov AV
    Expert Rev Neurother; 2014 Aug; 14(8):879-92. PubMed ID: 24984941
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Thrombolysis beyond 3 hours for acute ischaemic stroke.
    Selvaratnam R; Srirangalingam U; Ahmad S; Goulden P
    Emerg Med J; 2009 Oct; 26(10):756-7. PubMed ID: 19773512
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravenous thrombolysis for acute ischemic stroke: past, present and future].
    Hayakawa M
    Rinsho Shinkeigaku; 2014; 54(12):1197-9. PubMed ID: 25672743
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Thrombolysis for acute ischemic stroke.
    Hajjar K; Kerr DM; Lees KR
    J Vasc Surg; 2011 Sep; 54(3):901-7. PubMed ID: 21889708
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue plasminogen activator thrombolytic therapy for acute ischemic stroke in 4 hospital groups in Japan.
    Kono S; Deguchi K; Morimoto N; Kurata T; Deguchi S; Yamashita T; Ikeda Y; Matsuura T; Narai H; Omori N; Manabe Y; Yunoki T; Takao Y; Kawata S; Kashihara K; Abe K
    J Stroke Cerebrovasc Dis; 2013 Apr; 22(3):190-6. PubMed ID: 21968092
    [TBL] [Abstract][Full Text] [Related]  

  • 18. THrombolysis for Acute Wake-up and unclear-onset Strokes with alteplase at 0·6 mg/kg (THAWS) Trial.
    Koga M; Toyoda K; Kimura K; Yamamoto H; Sasaki M; Hamasaki T; Kitazono T; Aoki J; Seki K; Homma K; Sato S; Minematsu K;
    Int J Stroke; 2014 Dec; 9(8):1117-24. PubMed ID: 25088843
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Intra-arterial or intravenous thrombolysis for acute ischemic stroke? The SYNTHESIS pilot trial.
    Ciccone A; Valvassori L; Ponzio M; Ballabio E; Gasparotti R; Sessa M; Scomazzoni F; Tiraboschi P; Sterzi R;
    J Neurointerv Surg; 2010 Mar; 2(1):74-9. PubMed ID: 21990564
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Utilization of intravenous thrombolysis in 3-4.5 hours: analysis of the Minnesota stroke registry.
    Tekle WG; Chaudhry SA; Hassan AE; Peacock JM; Lakshminarayan K; Tsai A; Luepker R; Anderson DC; Qureshi AI
    Cerebrovasc Dis; 2012; 34(5-6):400-5. PubMed ID: 23221276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.